Src Family Kinases Are Regulated in Multiple Myeloma Cells by Phosphatase of Regenerating Liver-3
Published version of a preprint
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Phosphatase of regenerating liver-3 (PTP4A3/PRL-3) is a dual-specificity phosphatase that is upregulated in various types of cancers and is related to poor prognosis and aggressive tumor behavior. The expression level of PRL-3 is elevated in response to several antiapoptotic cytokines, including IL6, in cancer cells from patients with multiple myeloma (MM) and can promote survival and migration. Here, it is demonstrated that PRL-3 activates Src kinase in the IL6-dependent MM cell line INA-6. Inhibition of PRL-3 by a small-molecule inhibitor of PRL-3 or by shRNA resulted in inactivation of Src. In addition to activation of Src, PRL-3 also activated the Src family kinase (SFK) members LYN and HCK in INA-6 cells. Forced expression of catalytically inactive mutant PRL-3 decreased the activation of these three SFK members while the total level of HCK and FYN remained elevated. Inhibitors of Src increased sensitivity of cells overexpressing PRL-3 to the PRL-3 inhibitor through joint downregulation of both PRL-3 and Mcl-1. In conclusion, PRL-3 protected MM cells against apoptosis by dysregulating both the total levels and the activation levels of specific SFK members that are important for IL6 signal transduction in MM cells. Eventually, this led to increased levels of Mcl-1. Implications: This study suggests PRL-3 and SFKs are key mediators of the IL6-driven signaling events and points to both PRL-3 and SFK members as potential targets for treatment of MM. Mol Cancer Res; 15(1); 69–77. ©2016 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, in multiple myeloma cells, SFKs have been implicated in MCL-1 regulation through a process involving the phosphatase of regenerating liver-3 (PRL-3), and Src inhibitors down-regulate this protein.25”
From Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia (2025) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yeatman, T. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1366 · Cited by 1,113 · cited 1×
“Overexpression and activation of SFK members promotes development of various human cancers (9, 10).”
BackgroundStructure and regulation of Src family kinases
Boggon, T. J., & Eck, M. J. (2004) · Oncogene · doi:10.1038/sj.onc.1208081 · Cited by 712 · cited 1×
“Removal of this inhibitory phosphate reverses the conformation and leads to full catalytic activity of Src by autophosphorylation on Tyr416 (12, 13).”
BackgroundOsteoprotegerin is bound, internalized, and degraded by multiple myeloma cells.
Standal, T., Seidel, C., Hjertner, Ø., Plesner, T., Sanderson, R. D., Waage, A., Borset, M., & Sundan, A. (2002) · Blood · doi:10.1182/blood-2002-04-1190 · Cited by 244 · cited 8×
“Mol Cancer Res; 15(1) January 2017 Molecular Cancer Research 70”
Background
Research works printed but not linked: 35
- Chatterjee, 2004, Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells, Blood, 104, 3712, 10.1182/blood-2004-04-1670 · DOI · Paper page
- Andrews, 2013, Multiple myeloma: the bone marrow microenvironment and its relation to treatment, Br J Biomed Sci, 70, 110, 10.1080/09674845.2013.11669945 · DOI
- Mahindra, 2010, Multiple myeloma: biology of the disease, Blood Reviews, 24, S5, 10.1016/S0268-960X(10)70003-5 · DOI
- Frassanito, 2001, Autocrine interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis, Blood, 97, 483, 10.1182/blood.V97.2.483 · DOI · Paper page
- Brocke-Heidrich, 2004, Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation, Blood, 103, 242, 10.1182/blood-2003-04-1048 · DOI · Paper page
- Ogata, 1997, IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade, J Immunol, 159, 2212, 10.4049/jimmunol.159.5.2212 · DOI · Paper page
- Sen, 2011, Regulation of SRC family kinases in human cancers, J Signal Transduct, 2011, 865819, 10.1155/2011/865819 · DOI · Paper page
- Parsons, 2004, Src family kinases, key regulators of signal transduction, Oncogene, 23, 7906, 10.1038/sj.onc.1208160 · DOI · Paper page
- Ishikawa, 2003, Interleukin-6-induced proliferation of human myeloma cells associated with CD45 molecules, Int J Hematol, 78, 95, 10.1007/BF02983376 · DOI
- Sicheri, 1997, Crystal structure of the Src family tyrosine kinase Hck, Nature, 385, 602, 10.1038/385602a0 · DOI · Paper page
- Fagerli, 2008, Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells, Blood, 111, 806, 10.1182/blood-2007-07-101139 · DOI
- Campbell, 2014, Phosphatase of regenerating liver: a novel target for cancer therapy, Expert Opin Ther Tar, 18, 555, 10.1517/14728222.2014.892926 · DOI
- Hu, 2013, Poor prognosis of phosphatase of regenerating liver 3 expression in gastric cancer: a meta-analysis, PLoS One, 8, e76927, 10.1371/journal.pone.0076927 · doi:10.1371/journal.pone.0076927
- Dong, 2016, PRL-3 promotes migration and invasion and is associated with poor prognosis in salivary adenoid cystic carcinoma, J Oral Pathol Med, 45, 111, 10.1111/jop.12331 · DOI
- Broyl, 2010, Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients, Blood, 116, 2543, 10.1182/blood-2009-12-261032 · DOI · Paper page
- Kobayashi, 2014, Phosphatase of regenerating liver in hematopoietic stem cells and hematological malignancies, Cell Cycle, 13, 2827, 10.4161/15384101.2014.954448 · DOI
- Zhou, 2011, PRL-3, a metastasis associated tyrosine phosphatase, is involved in FLT3-ITD signaling and implicated in anti-AML therapy, PLoS One, 6, e19798, 10.1371/journal.pone.0019798 · DOI
- Zhou, 2012, The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia, Mol Cancer, 11, 72, 10.1186/1476-4598-11-72 · DOI
- Slordahl, 2016, The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells, Oncotarget, 7, 27295, 10.18632/oncotarget.8422 · DOI
- Hausherr, 2007, Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases, Oncogene, 26, 4987, 10.1038/sj.onc.1210306 · DOI
- Hallek, 1997, Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell lines, Exp Hematol, 25, 1367
- Walls, 2013, Phosphatase of regenerating liver 3 (PRL3) provokes a tyrosine phosphoproteome to drive prometastatic signal transduction, Mol Cell Proteomics, 12, 3759, 10.1074/mcp.M113.028886 · DOI
- Zimmerman, 2014, Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motility, J Biol Chem, 289, 5904, 10.1074/jbc.M113.480038 · DOI
- Fiordalisi, 2013, Src-mediated phosphorylation of the tyrosine phosphatase PRL-3 is required for PRL-3 promotion of Rho activation, motility and invasion, Plos One, 8, 10.1371/journal.pone.0064309 · DOI · Paper page
- Liang, 2007, PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation, J Biol Chem, 282, 5413, 10.1074/jbc.M608940200 · DOI · Paper page
- Liang, 2008, Translational control of C-terminal Src kinase (Csk) expression by PRL3 phosphatase, J Biol Chem, 283, 10339, 10.1074/jbc.M708285200 · DOI
- Tsubaki, 2014, By inhibiting Src, verapamil and dasatinib overcome multidrug resistance via increased expression of Bim and decreased expressions of MDR1 and survivin in human multidrug-resistant myeloma cells, Leuk Res, 38, 121, 10.1016/j.leukres.2013.10.017 · DOI
- Coluccia, 2008, Validation of PDGFRbeta and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib, Blood, 112, 1346, 10.1182/blood-2007-10-116590 · DOI
- Heusschen, 2016, SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma, Oncotarget, 7, 30712, 10.18632/oncotarget.8750 · DOI
- Geahlen, 2004, Molecular interdiction of Src-family kinase signaling in hematopoietic cells, Oncogene, 23, 8024, 10.1038/sj.onc.1208078 · DOI
- Ishikawa, 2002, Requirements of src family kinase activity associated with CD45 for myeloma cell proliferation by interleukin-6, Blood, 99, 2172, 10.1182/blood.V99.6.2172 · DOI
- Ishikawa, 2003, Interleukin-6, CD45 and the src-kinases in myeloma cell proliferation, Leuk Lymphoma, 44, 1477, 10.3109/10428190309178767 · DOI
- Podar, 2004, Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cells, J Biol Chem, 279, 21658, 10.1074/jbc.M305783200 · DOI
- Chandrasekharan, 2002, Characterization of mice deficient in the Src family nonreceptor tyrosine kinase Frk/rak, Mol Cell Biol, 22, 5235, 10.1128/MCB.22.14.5235-5247.2002 · DOI
- Calautti, 1998, Tyrosine phosphorylation and src family kinases control keratinocyte cell-cell adhesion, J Cell Biol, 141, 1449, 10.1083/jcb.141.6.1449 · DOI · Paper page
Cited by
Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia
Hu, X., Li, L., Nkwocha, J., Kmieciak, M., Shang, S., Cowart, L. A., Yue, Y., Horimoto, K., Hawkridge, A., Rijal, A., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02125-x · Cited by 15
Metadata
- Authors
- Abdollahi, P., Vandsemb, E. N., Hjort, M. A., Misund, K., Holien, T., Sponaas, A.-M., Rø, T. B., Slørdahl, T. S., & Børset, M.
- Affiliations
- 1Department of Cancer Research and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
- Venue
- Molecular Cancer Research
- Published
- 2017-01-01
- Volume
- 15
- Issue
- 1
- Pages
- 69-77
- ISSN
- 1541-7786
- 1557-3125
- Cited by
- 17
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Src Family Kinases Are Regulated in Multiple Myeloma Cells by Phosphatase of Regenerating Liver-3. https://app.cochat.ai/papers/10.1158/1541-7786.mcr-16-0212
- The paper
- Abdollahi, P., Vandsemb, E. N., Hjort, M. A., Misund, K., Holien, T., Sponaas, A.-M., Rø, T. B., Slørdahl, T. S., & Børset, M. (2017). Src Family Kinases Are Regulated in Multiple Myeloma Cells by Phosphatase of Regenerating Liver-3. Molecular Cancer Research. https://doi.org/10.1158/1541-7786.mcr-16-0212
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.